Skip to main content
The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
eHandbooks & White Papers
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Development
stevanatofinal
Drug Delivery
Stevanato expects lower revenue from GLP-1s in 2027
The company said it’s taking actions to offset the financial impact next year through increased demand in non-GLP-1 biologics and other high-value products.
Nov. 4, 2026
peptides_shutterstockfinal
Process Development
Why peptide developers are turning to CDMOs earlier in the development process
Aug. 19, 2026
automatedpharma_shutterstock
Process Development
Beyond better chemistry: The evolution of pharma process development
June 25, 2026
fda
FDA proposes using existing science, regulatory knowledge for gene therapy development
June 3, 2026
mushroomslabgloves
Plant-based drugs gain momentum amid manufacturing challenges
May 8, 2026
japanlabshutterstockfinal
Japanese pharma companies engage CDMOs earlier in development: Neuland Labs
May 4, 2026
fda
Process Development
FDA’s plausible mechanism framework presents CMC challenges
May 1, 2026
genetherapy_shutterstock
Process Development
CMC for cell and gene therapies remains a ‘learning curve’ for Big Pharma
April 29, 2026
neionbioegg
Process Development
Neion Bio emerges with egg-based biologics platform, biosimilar deal
April 21, 2026
Looking for Something?
Load More Content